Ham test

From WikiMD's WELLNESSPEDIA

Ham test is a medical diagnostic test used to identify Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare genetic disorder that causes the destruction of red blood cells. The test is named after Dr. Thomas Hale Ham, who first described the procedure in 1937.

Overview[edit]

The Ham test, also known as the acidified serum test, is a laboratory method used to diagnose PNH. The test is based on the principle that red blood cells from individuals with PNH are more susceptible to complement-mediated lysis when exposed to mildly acidified serum.

Procedure[edit]

In the Ham test, a patient's red blood cells are mixed with acidified serum at 37 degrees Celsius. If the red blood cells are lysed (broken down), the test is considered positive, indicating the presence of PNH.

Significance[edit]

The Ham test was the first diagnostic test for PNH and was widely used until the 1990s. However, it has largely been replaced by more sensitive and specific tests, such as flow cytometry. Despite this, the Ham test remains a significant part of the history of PNH research and diagnosis.

Limitations[edit]

While the Ham test was a breakthrough in PNH diagnosis, it has several limitations. The test can produce false-positive results in other hemolytic disorders, and it is less sensitive than newer diagnostic methods. Furthermore, the test requires fresh serum, which can be difficult to obtain and handle.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.